miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling.
Saved in:
| Title: | miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling. |
|---|---|
| Authors: | Han, Hu1,2 (AUTHOR), Li, Yan3 (AUTHOR), Qin, Wan1 (AUTHOR), Wang, Lu1 (AUTHOR), Yin, Han1 (AUTHOR), Su, Beibei1 (AUTHOR), Yuan, Xianglin1 (AUTHOR) yuanxianglin@hust.edu.cn |
| Source: | Cancer Cell International. 1/28/2022, Vol. 22 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14752867 |
|---|---|
| DOI: | 10.1186/s12935-022-02460-x |